Literature DB >> 27497687

New gold carbene complexes as candidate anticancer agents.

Alessandro Pratesi1, Damiano Cirri1, Mirjana D Đurović2, Serena Pillozzi3, Giulia Petroni3, Živadin D Bugarčić4, Luigi Messori5.   

Abstract

Three structurally related gold(I) carbene complexes with bulky hydrophobic ligands i.e. 1-3 were investigated in solution for further consideration as candidate anticancer agents. Cytotoxic assays were subsequently conducted on bone marrow-derived preosteoclast cell line of human origin (FLG 29.1) and human colon cancer cells (HCT-116). A far greater cytotoxic activity was measured for compound 1 against HCT-116 cells compared to 2 and 3; conversely, all compounds were highly and similarly active against FLG 29.1 cells. Results obtained for the reaction of complexes 1 and 2 with RNase A documented the occurrence of a weak interaction with this model protein and the formation of a tiny amount of the corresponding adduct. Moreover, a certain reactivity of the complex 2 was also detected toward GSH. The general implications of the obtained results are discussed.

Entities:  

Keywords:  Anticancer drugs; ESI–MS; Gold carbene; Protein interaction

Mesh:

Substances:

Year:  2016        PMID: 27497687     DOI: 10.1007/s10534-016-9962-0

Source DB:  PubMed          Journal:  Biometals        ISSN: 0966-0844            Impact factor:   2.949


  6 in total

Review 1.  Gold as a Possible Alternative to Platinum-Based Chemotherapy for Colon Cancer Treatment.

Authors:  Inés Mármol; Javier Quero; María Jesús Rodríguez-Yoldi; Elena Cerrada
Journal:  Cancers (Basel)       Date:  2019-06-05       Impact factor: 6.639

2.  Metal complexes of benzimidazole-derived as potential anti-cancer agents: synthesis, characterization, combined experimental and computational studies.

Authors:  Van-Thanh Nguyen; Thi-Kim-Chi Huynh; Gia-Thien-Thanh Ho; Thi-Hong-An Nguyen; Thi Le Anh Nguyen; Duy Quang Dao; Tam V T Mai; Lam K Huynh; Thi-Kim-Dung Hoang
Journal:  R Soc Open Sci       Date:  2022-09-21       Impact factor: 3.653

3.  Antiproliferative effects of two gold(I)-N-heterocyclic carbene complexes in A2780 human ovarian cancer cells: a comparative proteomic study.

Authors:  Francesca Magherini; Tania Fiaschi; Elisa Valocchia; Matteo Becatti; Alessandro Pratesi; Tiziano Marzo; Lara Massai; Chiara Gabbiani; Ida Landini; Stefania Nobili; Enrico Mini; Luigi Messori; Alessandra Modesti; Tania Gamberi
Journal:  Oncotarget       Date:  2018-06-15

4.  Reactions of Medicinal Gold(III) Compounds With Proteins and Peptides Explored by Electrospray Ionization Mass Spectrometry and Complementary Biophysical Methods.

Authors:  Lara Massai; Carlotta Zoppi; Damiano Cirri; Alessandro Pratesi; Luigi Messori
Journal:  Front Chem       Date:  2020-10-21       Impact factor: 5.221

5.  Mechanistic Insights Into the Anticancer Properties of the Auranofin Analog Au(PEt3)I: A Theoretical and Experimental Study.

Authors:  Iogann Tolbatov; Damiano Cirri; Lorella Marchetti; Alessandro Marrone; Cecilia Coletti; Nazzareno Re; Diego La Mendola; Luigi Messori; Tiziano Marzo; Chiara Gabbiani; Alessandro Pratesi
Journal:  Front Chem       Date:  2020-09-18       Impact factor: 5.221

6.  Native mass spectrometry of human carbonic anhydrase I and its inhibitor complexes.

Authors:  Carlotta Zoppi; Alessio Nocentini; Claudiu T Supuran; Alessandro Pratesi; Luigi Messori
Journal:  J Biol Inorg Chem       Date:  2020-09-14       Impact factor: 3.358

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.